175 related articles for article (PubMed ID: 34277606)
21. RNA m6A Methylation Regulators Multi-Omics Analysis in Prostate Cancer.
Su H; Wang Y; Li H
Front Genet; 2021; 12():768041. PubMed ID: 34899855
[TBL] [Abstract][Full Text] [Related]
22. Integrative Analysis of NSCLC Identifies LINC01234 as an Oncogenic lncRNA that Interacts with HNRNPA2B1 and Regulates miR-106b Biogenesis.
Chen Z; Chen X; Lei T; Gu Y; Gu J; Huang J; Lu B; Yuan L; Sun M; Wang Z
Mol Ther; 2020 Jun; 28(6):1479-1493. PubMed ID: 32246902
[TBL] [Abstract][Full Text] [Related]
23. Expression Pattern and Prognostic Value of Key Regulators for m6A RNA Modification in Hepatocellular Carcinoma.
Zhang L; Qiao Y; Huang J; Wan D; Zhou L; Lin S; Zheng S
Front Med (Lausanne); 2020; 7():556. PubMed ID: 33072775
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive analysis of m6A regulators prognostic value in prostate cancer.
Ji G; Huang C; He S; Gong Y; Song G; Li X; Zhou L
Aging (Albany NY); 2020 Jul; 12(14):14863-14884. PubMed ID: 32710725
[TBL] [Abstract][Full Text] [Related]
25. HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma.
Jia C; Guo Y; Chen Y; Wang X; Xu Q; Zhang Y; Quan L
J Transl Med; 2022 Nov; 20(1):537. PubMed ID: 36401285
[TBL] [Abstract][Full Text] [Related]
26. LncRNA ELFN1-AS1 promotes esophageal cancer progression by up-regulating GFPT1 via sponging miR-183-3p.
Zhang C; Lian H; Xie L; Yin N; Cui Y
Biol Chem; 2020 Aug; 401(9):1053-1061. PubMed ID: 32229685
[TBL] [Abstract][Full Text] [Related]
27. Down-Regulation of miR-2053 Inhibits the Development and Progression of Esophageal Carcinoma by Targeting Fyn-Related Kinase (FRK).
Wang B; Zhang L; Li J; Hua P; Zhang Y
Dig Dis Sci; 2020 Oct; 65(10):2853-2862. PubMed ID: 31894485
[TBL] [Abstract][Full Text] [Related]
28. HNRNPA2B1 and HNRNPR stabilize ASCL1 in an m6A-dependent manner to promote neuroblastoma progression.
Hu T; Zeng C; Song Z; Liu Q; Chen S; Huang W; Ma Q; Li H
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167050. PubMed ID: 38331110
[TBL] [Abstract][Full Text] [Related]
29. hnRNPA2B1 Promotes Colon Cancer Progression via the MAPK Pathway.
Tang J; Chen Z; Wang Q; Hao W; Gao WQ; Xu H
Front Genet; 2021; 12():666451. PubMed ID: 34630502
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive Analysis of YTHDF1 Immune Infiltrates and ceRNA in Human Esophageal Carcinoma.
Liu XS; Kui XY; Gao Y; Chen XQ; Zeng J; Liu XY; Zhang Y; Zhang YH; Pei ZJ
Front Genet; 2022; 13():835265. PubMed ID: 35401696
[No Abstract] [Full Text] [Related]
31. The m6A readers
Anita R; Paramasivam A; Priyadharsini JV; Chitra S
Am J Cancer Res; 2020; 10(8):2546-2554. PubMed ID: 32905518
[TBL] [Abstract][Full Text] [Related]
32. Construction and investigation of β3GNT2-associated regulatory network in esophageal carcinoma.
Luo Z; Hu Q; Tang Y; Leng Y; Tian T; Tian S; Huang C; Liu A; Deng X; Shen L
Cell Mol Biol Lett; 2022 Jan; 27(1):8. PubMed ID: 35073841
[TBL] [Abstract][Full Text] [Related]
33. Expression and clinical prognostic value of m6A RNA methylation modification in breast cancer.
Zheng F; Du F; Qian H; Zhao J; Wang X; Yue J; Hu N; Si Y; Xu B; Yuan P
Biomark Res; 2021 Apr; 9(1):28. PubMed ID: 33926554
[TBL] [Abstract][Full Text] [Related]
34. [MiR-204 inhibits invasion and metastasis of breast cancer cells by targeted regulation of HNRNPA2B1].
Zhang L; Bai J; Hu Y; Zhou D; Zheng Q; Yin C; Mu Q; Li H
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jun; 40(6):869-875. PubMed ID: 32895200
[TBL] [Abstract][Full Text] [Related]
35. Effects of EFNA1 on cell phenotype and prognosis of esophageal carcinoma.
Zhang Y; Zhang J; Pan G; Guan T; Zhang C; Hao A; Li Y; Ren H
World J Surg Oncol; 2021 Aug; 19(1):242. PubMed ID: 34399788
[TBL] [Abstract][Full Text] [Related]
36. lncRNA PCAT6 facilitates cell proliferation and invasion via regulating the miR-326/hnRNPA2B1 axis in liver cancer.
Luo J; Zheng J; Hao W; Zeng H; Zhang Z; Shao G
Oncol Lett; 2021 Jun; 21(6):471. PubMed ID: 33907581
[TBL] [Abstract][Full Text] [Related]
37. m6A reading protein RBMX as a biomarker for prognosis and tumor progression in esophageal cancer.
Tuersun H; Liu L; Zhang J; Maimaitizunong R; Tang X; Li H
Transl Cancer Res; 2023 Sep; 12(9):2319-2335. PubMed ID: 37859733
[TBL] [Abstract][Full Text] [Related]
38. Gene Signatures and Prognostic Values of m6A Regulators in Hepatocellular Carcinoma.
Wang P; Wang X; Zheng L; Zhuang C
Front Genet; 2020; 11():540186. PubMed ID: 33133142
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-454-3p inhibits cell proliferation and invasion in esophageal cancer by targeting insulin-like growth factor 2 mRNA-binding protein 1.
Yan A; Wang C; Zheng L; Zhou J; Zhang Y
Oncol Lett; 2020 Dec; 20(6):359. PubMed ID: 33133259
[TBL] [Abstract][Full Text] [Related]
40. Functional enrichment analysis reveals the involvement of DARS2 in multiple biological pathways and its potential as a therapeutic target in esophageal carcinoma.
Liu XS; Liu ZY; Zeng DB; Hu J; Chen XL; Gu JL; Gao Y; Pei ZJ
Aging (Albany NY); 2024 Feb; 16(4):3934-3954. PubMed ID: 38382106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
